Loading…
Loading…
Emerging markets equities and the related ETFs are delivering some impressive performances this year. Still, savvy advisors and investors look beyond the headlines.
Emerging markets equities and the related broad-based ETFs are building on momentum accrued last year. They've delivered impressive performances again in 2026.
Ever since conflict erupted in the Middle East a few months ago, the topic of geopolitical uncertainty has remained fresh in the minds of advisors and investors alike. For this edition of Bull vs.
It has not exactly been a stretch to argue that international equities have enjoyed a significant resurgence in investor attention for well over a year now. These companies a great potential source of long-term returns.
Even the tidal wave of tariffs wasn't enough to hold back the rally in global equities last year. As it turns out, emerging markets were the single best-performing major regional indices in 2025.
Even the tidal wave of tariffs wasn't enough to hold back the rally in global equities last year. As it turns out, emerging markets were the single best-performing major regional indices in 2025.
Biotech and natural resources funds led the ALPS ETFs lineup in 2025, with both strategies delivering returns above 45%, according to ETF Database. The ALPS Medical Breakthroughs ETF (SBIO) gained just over 57% through December 23, topping all ALPS products for the year, according to ETF Database.
Biotech and natural resources funds led the ALPS ETFs lineup in 2025, with both strategies delivering returns above 45%, according to ETF Database. The ALPS Medical Breakthroughs ETF (SBIO) gained just over 57% through December 23, topping all ALPS products for the year, according to ETF Database.